These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15772306)

  • 1. The role of the 132-160 region in prion protein conformational transitions.
    Torrent J; Alvarez-Martinez MT; Liautard JP; Balny C; Lange R
    Protein Sci; 2005 Apr; 14(4):956-67. PubMed ID: 15772306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical studies of conformational plasticity in a recombinant prion protein.
    Zhang H; Stockel J; Mehlhorn I; Groth D; Baldwin MA; Prusiner SB; James TL; Cohen FE
    Biochemistry; 1997 Mar; 36(12):3543-53. PubMed ID: 9132005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
    Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
    J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow conformational dynamics in the hamster prion protein.
    Kuwata K; Kamatari YO; Akasaka K; James TL
    Biochemistry; 2004 Apr; 43(15):4439-46. PubMed ID: 15078089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative prion structural changes revealed by high pressure.
    Torrent J; Alvarez-Martinez MT; Heitz F; Liautard JP; Balny C; Lange R
    Biochemistry; 2003 Feb; 42(5):1318-25. PubMed ID: 12564935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity.
    Safar J; Roller PP; Gajdusek DC; Gibbs CJ
    Protein Sci; 1993 Dec; 2(12):2206-16. PubMed ID: 7905316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between the prion protein and its homolog Doppel: a partially structured state with implications for scrapie formation.
    Nicholson EM; Mo H; Prusiner SB; Cohen FE; Marqusee S
    J Mol Biol; 2002 Feb; 316(3):807-15. PubMed ID: 11866533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypeptide chain folding in the hydrophobic core of hamster scrapie prion: analysis by X-ray diffraction.
    Inouye H; Kirschner DA
    J Struct Biol; 1998; 122(1-2):247-55. PubMed ID: 9724626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural dependence of the cellular isoform of prion protein on solvent: spectroscopic characterization of an intermediate conformation.
    Pergami P; Bramanti E; Ascoli GA
    Biochem Biophys Res Commun; 1999 Nov; 264(3):972-8. PubMed ID: 10544040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational changes and development of proteinase K resistance in surface-immobilized PrP.
    Leclerc E; Vetter S
    Arch Virol; 2008; 153(4):683-91. PubMed ID: 18278426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of the pathogenic conformational change of the prion protein by an attractor of low order.
    Havsteen BH
    J Theor Biol; 2004 Nov; 231(1):39-48. PubMed ID: 15363928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA molecules stimulate prion protein conversion.
    Deleault NR; Lucassen RW; Supattapone S
    Nature; 2003 Oct; 425(6959):717-20. PubMed ID: 14562104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups.
    Lucassen R; Nishina K; Supattapone S
    Biochemistry; 2003 Apr; 42(14):4127-35. PubMed ID: 12680767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scrapie prion protein structural constraints obtained by limited proteolysis and mass spectrometry.
    Sajnani G; Pastrana MA; Dynin I; Onisko B; Requena JR
    J Mol Biol; 2008 Sep; 382(1):88-98. PubMed ID: 18621059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form.
    Jansen K; Schäfer O; Birkmann E; Post K; Serban H; Prusiner SB; Riesner D
    Biol Chem; 2001 Apr; 382(4):683-91. PubMed ID: 11405232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-level expression and characterization of a purified 142-residue polypeptide of the prion protein.
    Mehlhorn I; Groth D; Stöckel J; Moffat B; Reilly D; Yansura D; Willett WS; Baldwin M; Fletterick R; Cohen FE; Vandlen R; Henner D; Prusiner SB
    Biochemistry; 1996 Apr; 35(17):5528-37. PubMed ID: 8611544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The key-role of tyrosine 155 in the mechanism of prion transconformation as highlighted by a study of sheep mutant peptides.
    Bertho G; Bouvier G; Hoa GH; Girault JP
    Peptides; 2008 Jul; 29(7):1073-84. PubMed ID: 18455265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of detergents on the secondary structures of prion protein peptides as studied by CD spectroscopy.
    Kuroda Y; Maeda Y; Sawa S; Shibata K; Miyamoto K; Nakagawa T
    J Pept Sci; 2003 Apr; 9(4):212-20. PubMed ID: 12725242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The elusive intermediate on the folding pathway of the prion protein.
    Jenkins DC; Sylvester ID; Pinheiro TJ
    FEBS J; 2008 Mar; 275(6):1323-35. PubMed ID: 18279390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.